Abstracts Archive - Page 567 of 1683 - ATC Abstracts

2019 American Transplant Congress
Perception Of Hospital Staff On Transplant: Pre And Post-intervention
J. Wise¹, A. Sarvestani¹, K. Briggs², J. Malik², M. Ott³, L. Markham³, H. Wilkins³, D. Neel², C. Richart⁴, J. Foxworth¹, M. Moncure²
¹University of Missouri - Kansas City, Kansas City, MO, ²Department of Surgery, University of Missouri - Kansas City, Kansas City, MO, ³Midwest Transplant Network, Kansas City, MO, ⁴Northeast Georgia Medical Center, Gainesville, GA
*Purpose: A primary component in managing potential organ donors is working effectively and collaboratively in the multidisciplinary environment of the ICU. Fundamentals of Critical Care…
2019 American Transplant Congress
Evaluating Potentially Inappropriate Prescribing in Older Kidney Transplant Recipients
L. DeVietro¹, B. Richardson², E. A. Cohen³, A. H. Toledo⁴, E. Marin⁵, K. R. Szempruch⁶
¹University of St. Joseph School of Pharmacy, Hartford, CT, ²University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, ³Pharmacy, Yale New Haven Hospital, New Haven, CT, ⁴Surgery-Transplant, University of North Carolina Medical Center, Chapel Hill, NC, ⁵Nephrology, Yale New Haven Hospital, New Haven, CT, ⁶Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC
*Purpose: While the Beers criteria (BC) and STOPP criteria (SC) have been validated in several patient populations to reduce medication use leading to adverse drug…
2019 American Transplant Congress
Page Kidney Phenomenon in a Trauma Patient: A Case Report and Recommendations for Management
M. M. Estrada, D. R. Hall, W. Dar, J. S. Bynon
University of Texas Health Science Center at Houston, Houston, TX
*Purpose: Unintentional injuries result in over 30 million emergency room visits annually in the United States. With almost 20 thousand renal transplants performed in 2017,…
2019 American Transplant Congress
Impact of Case Scheduling on Hospital Cost and Length of Stay in Living Donor Kidney Recipients
J. Yu¹, L. A. Dageforde², M. B. Doyle¹, A. S. Khan¹, W. C. Chapman¹, Y. Lin¹, S. Shenoy¹, T. Alhamad³, T. A. Horwedel⁴, J. R. Wellen¹
¹Surgery, Washington University School of Medicine, St. Louis, MO, ²Surgery, Massachusetts General Hospital, Boston, MA, ³Medicine, Washington University School of Medicine, St. Louis, MO, ⁴Barnes-Jewish Hospital, St. Louis, MO
*Purpose: In an effort to optimize patient care and cost efficiency, we investigated if living donor kidney transplant (LDKT) recipients incurred any difference in hospital…
2019 American Transplant Congress
Early Readmission After Renal Transplant As A Valuable Quality Measure
S. Kim¹, A. Osband¹, B. Merhi², G. Bayliss², R. Gohh², P. Morrissey¹
¹Surgery, Rhode Island Hospital, Providence, RI, ²Nephrology, Rhode Island Hospital, Providence, RI
*Purpose: Patient and graft survival have been criticized as imprecise measures of transplant program quality. Thirty-day (30d) readmission rates, available nationally and attainable locally, may…
2019 American Transplant Congress
Liver Waitlist Dropout and Transplant Rates for Metropolitan vs. Non-Metropolitan Candidates
D. Schladt¹, T. Weaver¹, J. Pyke¹, A. Herreid¹, B. Thompson¹, B. Kasiske¹, J. Snyder¹, W. Kim², J. Lake³, A. Israni¹
¹SRTR, Minneapolis, MN, ²Stanford Univ, Stanford, CA, ³Univ of Minnesota, Minneapolis, MN
*Purpose: Rural candidates may be disadvantaged on the liver waiting list. We evaluated rates and hazards of waitlist dropout and transplant by urbanicity.*Methods: We selected…
2019 American Transplant Congress
How Well Do Kidney Transplant Patients Understand Their Medications and Does Real-Time Assessment of Knowledge Improve Retention of Information?
B. Clark¹, B. Sirandas¹, T. Larson², A. Carlson¹, C. Truax¹, D. D. Ramirez¹, L. Smith¹, I. Hall¹
¹University of Utah Health, Salt Lake City, UT, ²Henry Ford Hospital, Detroit, MI
*Purpose: This study aims to evaluate the impact that early formal assessment and reteaching have on patient medication knowledge after renal transplant.*Methods: This was a…
2019 American Transplant Congress
Prolonged Heterotopic Cardiac Xenograft Survival from Thrombomudulin Expressing Multigene Donor Pig
A. K. Singh¹, L. DiChiacchio¹, T. Zhang¹, A. Hersfield¹, I. Tatarov¹, D. Parsell¹, B. Lewis¹, F. Sentz¹, D. Ayares², M. Mohiuddin¹
¹Department of Surgery, University of Maryland Baltimore, Baltimore, MD, ²Revivicor, Inc, Blacksburg, VA
*Purpose: Genetic engineering (GE) technology has made knockout and multigene expressing animals available. These animals can be used for xenotransplantation (xTX)to treat end stage diseases.…
2019 American Transplant Congress
Absence of Antibodies in Human Neonates and Infants to Gtko/cmahko/β4galnt2ko (Triple Gene Knockout) Pig Cells: Relevance to Cardiac Xenotransplantation for Complex Congenital Heart Disease
H. Hara¹, Q. Li¹, C. A. Banks¹, T. Yamamoto¹, D. Ayares², D. C. Cleveland¹, D. K. Cooper¹
¹Surgery, University of Alabama at Birmingham, Birmingham, AL, ²Revivicor Inc., Blacksburg, VA
*Purpose: Heart transplantation (Tx) in neonates is associated with the best results of any organ Tx, but the lack of deceased human donor hearts in…
2019 American Transplant Congress
The Effect of Intravenous Immunoglobulin on Human Complement-Dependent Cytotoxicity of Pig Cells: Benefit? Or Harm?
T. Yamamoto¹, Q. Li¹, A. Banks¹, H. Iwase¹, D. Ayares², D. K. Cooper¹, H. Hara¹
¹Xenotransplantation Program, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, ²Revivicor, Blacksburg, VA
*Purpose: Xenoreactive antibodies and complement play an important role in pig xenograft rejection. Intravenous immunoglobulin (IVIG) is widely used in desensitization protocols and for the…